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0bjt#ives. This study sought to detw&e the bemafynamic 
effects of oxygen tberapy in heart failore. 
BnekgrouRd High dose oxygen has detrimental hemodynamic 
elf&s in normal sob&&, yet oxygen is a common tberapy for 
heart t&lure. Wktber oxygen alters hemodynamic variables in 
beart kihue is unknown. 
h&ho& We studied 10 patients with New York Ikart Associ- 
ation fimctional class fll and IV coqstive beart More who 
inhaled room air and 100% oxygen for 20 min. Variables measured 
incbuJed cardiac oatput, stroke volume, pulmonary capillary 
wedge pressure, systemic and pulmonary vaactdar resistawe, 
mean arterial pressme and heart rate. Graded oxygen cxmconti- 
tions were also stndied (room air, 24%, 40% and 100% m 
respectively; n = 7). ln five separate patients, muscle symfmthetic 
nerve activity and ventilation were measured durtng 180% oxygen. 
Patients with severe congestive heart failure are often dyspneic 
and hypoxic. In patients with oxygen saturation <!IO%, it is 
recommended that supplemental oxygen be given (1). How- 
ever, it has been our impression that supplemental oxygen is 
often used empirically without an appropriate assessment of 
blood oxygen saturation. Despite the frequent use of supple- 
mental oxygen, there has been little investigation of its effects 
on hemodynamic variables in heart failure. This would seem an 
important area of investigation because 1) previous studies in 
normal subjects have suggested that 100% oxygen administra- 
tion may lower cardiac output and raise peripheral vascular 
resistance (2-4), and 2) cardiac output may be precarious!y 
low and vascular resistance excessively high in patients wi.h 
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Rewk Tbe 100% oxygen redoced card& output tfmm 3.7 fi 
0.3 to 3.1 2 0.4 liters/mio [awan + SE], p c 0.01) and strobe 
volume(from46~4to38~5ml~tplrmin,pCO.Ol)and 
increaApulmonarycapillaqwedgepressure(from2Si2to 
29i:3~EI&pCO.H)sndsys~vPseulnrrPsistanco(froa 
l&28 + 154 to 2Ja3 Ic_ 199 dynes-skm~, p C 0‘01). Graded oxygen 
iedtoaprogrwivede&ineincardiacoutput(one-wayanatysisof 
varbine p C 0.0001) and strobe vohune (p C 0.017) aud an 
increase in systemtc vascelar resistance (p C 0.005). The l&I% 
oxygendidnotaltersympatlletica&ityorven- 
-.h~failn~oxygenbasadetrimeotal~mt 
eardiaeDII$Bt,strokeV~slae,~eepiunry=dlPP- 
sure~dsystemicvasc&arresistance.’ikeae areinde 
pendentufsympatheticactivityandventilatiosL 
(JAni coil Gwdiol1996;27:353-7) 
heart failure with rest symptoms (5). Accordingty, in the 
present report we examined the effects of various levels of 
supplemental oxygen on rest hemodynamic variables in sub- 
jec& with severe congestive heart failure. The results of our 
studies suggest that short-term supplemental oxygen can have 
a detrimental hemodynamic effect. 
Methods 
Subjects. We performed three separate experiments in 22 
subjects with congestive heart failure. The characteristics of 
these subjects are shown in Table 1. Au subjects were ad:mtted 
to the hospital for severe heart failure, and the major? were 
being evaluated for or&topic heart transplantation., 
In experiment 1 (10 subjec& (!kbjec6 1 to 10 in Tabie I]), 
we compared hemodynamic variabies during room an breath- 
ing to those observed after 100% suppkmentat oxygen was 
delivered by a nonrebreathing face mask ior 20 min. 0n the 
basis of the results of experiment 1, we performed experiment 
‘2 in which we zmtpared hemodynamic variables during room 
air breathing to those seen during three diierent levels of 
supplemental oxygen: 24%, 40% and 100% oxygen (seven 
subjects [Subjects 11 to 17 in Table 11). For 24% and 4096, 
0xygenwnsgivenbyafacemaskusingtheVenturitechni~ 
1th3%oxygeuwasagainde.liiredbyanomebre&ungrnask 
Eecausetberesultsoftktirsttwoexpe.rimf5nts6knon- 
strated that oxygen therapy lowered cardiac output and raised 
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Table 1. Clinical Characteristics of 22 Study Subjects 
Subject 
NO. 
I 
Age (yr)*/ NYHA Functional Ejection Fraction 
Genl+ Etiology of CHF Class Btimatcs (%)t 
-- 
51ff Idiopathic CM I!! IS 
2 57/F Idiopathic CM IV IS 
3 W/M kchemlc CM I!! 20 
4 52/M Va!vular CM IV IO 
5 55/M Ischemic CM I!! IS 
b 56/M Idiopathic CM III-IV IU 
7 54/M Ischemic CM :!I 35 
8 51,M Idiopathic CM 111 IO 
9 4OiM Hypertrophic CM I!! l!l 
IO S!:M Ischrmic CM IV IO 
II 5l:F Idiopathic CM IV 10 
I? WM Idiqxpathic CM IV IO 
13 64!= Idiopathic CM 111 20 
14 55/M Valvular CM IV IS 
I5 51/M Ischemic CM II! 15 
16 M!M Idiopathic CM I!! 20 
I7 62M Ischemic CM IV IS 
18 36,‘M Idiopathic CM I!! IO 
I9 75;M Ischemic CM IV 15 
20 45,‘hl Ischemic CM I!! 25 
21 49/M Ixhemic CM IV 15 
22 59/M khemic CM IV 15 
*Mean L SE age 53.3 2 2.1 years tFrom two-dimensional echocardiogmphy. All subjects were receiving the 
following cardiac medications: digotin, loop diuretic drugs, vawdilaton (i.e., angiotensin-convr~ing enzyme inhibitor or 
hydralazineinitrates). Four patients were rcceiting dopamine and dobutamine at the time of study. CHF = congestive 
heart failure; CM = cardiomyopathy: F = female; M = male: NYHA = New York Heart Aswciation. 
systemic vascular resistance, we performed experiment 3 in 
which we examined the effects of 100% ovgen on sympathetic 
nerve activity and ventilation (five subjects [Subjects 18 to 22 in 
Table 11). 
vascular resistance were calculated using standard formulas. 
The majority of subjects in experiments 1 and 2 were 
studied in the cardiac catheterization laboratory as part of a 
standard heart transplantation evaluation. The subjects in 
experiment 3 *zre studied in the intensive care unit or in the 
medical intermediate care unit. Written informed consent was 
obtained from each subject befcre any procedures were done. 
Experiment 1: e&t of 108% oxygen administration on 
bemodynamic variables. The subjects were studied in the 
supine position. Baseline Gables were recorded with the 
subjects breathing room air and after 20 min of breathing 
100% oxygen by a nonrebreather mask. No subject received 
sedatives during the experiments. 
Heart rate was measured continuously by electrocardio- 
graphy and blood pressure was recorded using an automated 
device that employed the oscillometric method (Dinamap). A 
Swan-Ganz catheter was inserted for the measurement of 
pressures, the determination of cardiac output (thermodilution 
method) and for the measurement of pulmonary artery oxygen 
saturations. Pressure measurements were read on a paper 
recording. Thermal dilution cardiac outputs represented the 
mean of three to live determinations. In experiments 1 and 2, 
15 of 17 experiments were performed by two operators (UC., 
J.B.). An ear or finger oximeter was used to estimate arterial 
oXygen saturation. Systemic vascular resistance and pulmonary 
Mixed venous oxygen content was cala;laied as 1.34 X Hemo- 
globin x Pulmonary artery oxygen saturation. Pulmonary 
artery oxygen saturation was determined using a co&meter. 
Experiment 2: effects of 24%, 40% aad 100% oxygen admin- 
istration on bemodyaamic variables. The design of experi- 
ment 2 was similar to that of experiment 1. Because of the 
number of interventions, the exposure to each level of supple- 
mental oxygen was 5 min hfore performing the measure- 
ments. In experiment 1, we gave 100% oxygen as the first (and 
only) intervention. Accordingly, in this experiment, 24% oxy- 
gen was the first intervention, and 100% oxygen was the last in 
the majority of subjects (five of seven). In two of seven subjects 
the sequence was reversed. 
Experiment 3: e&feet of 100% oxygen a&ninirtratioo on 
sympatbetie nerve a&@. Peroneal nerve recorulrlgs of mus- 
cle sympathetic nerve activity were our index of Sympathoex- 
citation. This technique provides a “direct” measure of sym- 
pathetic outflow directed to blood vessels in skeletal muscle 
(6). Multiunit sympathetic, nerve recordings were obtained by 
placing a tungsten microelectrode (200-pm shaft and 1 to 
5-pm tip) in a muscle fascicle within the peroneal nerve and a 
reference electrode in the adjacent subcutaneous tissue. The 
signal was amplified by a preamplifier (1,000X) and an amp& 
fier (50 to 90x). me raw signal was filtered (700 and 2,000 Hz) 
and integrated to obtain a mean voltage n~urograrn (6-8). 
This was manually anaIyzed by cotinting the number of bursts 
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Table 2. Hemodynamic Variables at Baseline and After 100% 
Oxygen Administration (experiment 1) a 
Cw%ac output (liters/min) 
Stroke vohune (ml&at) 
Puhnonmy capillary wedge prcswe 
(mm W 
Bdseline @wn 
3.7 2 0.3 3.1 + 0.4' 
4624 3825' 
2.522 29 + 3t 
Mean pulmonary artery pressure (mm Hg) 38 z 3 4213t 
Putmwary vascular resistance (dynesslcm~) 3oSt51 352 t_Sl 
Systemic vascalar resistance (dyness/cms) 1,628 _f 154 2,203 z 199’ 
Heart rate (beaWmin) 82 2 3 83 2 3 
Mean arterial pressure (mm Hg) 7922 8122 
Mixed ve”ws “xy~en content (ml/d]) 8.8 2 0.6 10.4 -r 0.6' 
‘p < 0.01. tp < 0.05. Data presented are mean value ? SE. 
b 
C 
per minute. Muscle sympathetic nerve activity was obtained at 
baseline and during breathing 108% oxygen for 5 min. 
Because of the potential intiuence of ventilation on sympa- 
thetic nerve activity (9), and because oxygen therapy might 
alter ventilation and sympathetic drive (lO,lI), we ako mea- 
sured ventilatoty variables (i.e., minute ventilation and end- 
tidal carbon dioxide) using a respiratoty gas monitor (Ohmeda 
5250). 
AnaIysis and stntistIcaI design. In experiments 1 and 3, the 
effects of 100% oxygen were analyzed using a paired t test. In 
experiment 2 the various levels of oxygen were analyzed using 
a one-way anaIysis of variance for repeated measures. When 
significant F values were found, pairwise comparisons were 
made using the Neuman-Keuk method (12). A p value ~0.05 
was considered statistically signilicant. Results are presented as 
mean value + SE. 
Fw 1. Hemodynamic changes with oxygen breathing in indiiual 
patients @pest circks). FCWP = puhxonaq capillary wedge pressure; 
SVR = systemic vascular resistance. Soiid circles = mean value ?r SE. 
‘p < 0.05. tp < 0.01. 
Results 
Experiment 1. Oxygen administration resulted in an in- 
crease in oxygen saturation (baseline 92.6 2 1.2%, oxygen 
therapy 99.8 + 0.2%, p c 0.0001). The mean value of oxygen 
saturation for 20 control subjects in our laboratory is 97.3 + 
0.3%. The hemodynamic responses to oqrgen adminktttion 
are displayed in Table 2, and individual data are presented in 
Figure 1. The 108% oxygen administration decreased cardiac 
output from 3.7 ? 0.3 to 3.1 + 0.4 liters/mm (p < 0.01) (Fig. 
la) and stroke volume from 46 2 4 to 38 2 5 m&eat (p < 
0.01). Pulmonary capillary wedge pressure increased from 
25 + 2 to 29 t 3 mm Hg (p < O.(M) (Fig. lb), and mean 
pulmonary artery pressure increased from 38.4 2 3.2 to 41.6 2 
3.4 mm Hg (p < 0.05). Systemic vasctdar resistance increased 
during oxygen admiitration, from 1,628 + 154 to 2,203 $ 199 
dynes$d (p < 0.01) (Fig. lc). 0xygen administration did not 
result in significant changes in mean arterial pressure, heart 
rate or puImonary vascukr resistance. Mixed venous oxygen 
content &teased from 8.8 5 0.6 to 10.4 2 0.6 ml/dI (p < 
0.002). 
oxygen ako led to a dose-dependent reduction in cardiac 
output such that the vahte at 24% was lower than that at 
baseline, that at 40% was lower thar the Ifi’% value, and that 
at 180% was lower than the 40% value c fab;ti 3. Fig 2). Stroke 
vohme ako declined with increasing levels of oxygen (F = 4.6, 
p < 0.017) (TabIe 3). Although pulmonary capiUary wedge 
pressure was higher during 180% than during baseline in six of 
seven subjects, there was no “main effect” of oxygen on 
pulmonary capillary wedge pressure (Table 3). If the seven 
subjects from experiment 2 were added to those in experiment 
1, the puhnonary capillary wedge ptmure at 108% oxygen 
wouldbegreaterthanthatatbgseline(baseline26-C2vs 
ltXt% oxygen 30 t 2 mm m p < 0.081). SuppIemental oxygen 
had no effect on mean puhnonary artery pressure (Table 3). 
Supplemental oxygen adminktmtion Led to a rise in systemic 
vascular txsdmce (F = 6.1, p < tl.005). Post hoc analysk 
demonstrated that the 1WZ oxygen value was different from 
the room air value. Although systemic vascular &stance 
during the 40% oxygen intervention was not statistic@ dif- 
ferent from the baseline v&e, it was greater at the higher 
oxygen level in six of the seven subjects studied. Ihe d&rent 
Ievek of suppIementaI oxygen did not change the other 
hemodymmk parameters except for cakulated mixed venous 
oxygen content, which rose as a function of osygen debvery 
(F = 5.9, p < O.oM). 
2 Oxygenadmi&rationIedtoaprogre&e 
rise in oxygen saturation (TabIe 3). Importantly, snppIemental 
3.AdmiioflfKl%osygendidnot 
resuhinasigni&mtchangeinmoscIesymp&+tterve 
activity (626 k 3.8 vi63.9 + 4.7 burstdmin, p = NS). Minute 
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Table 3. Hemodynamic Data (mean i SE) During Graded Oxygen Administration (experiment 2) 
CO (titers/min)’ (n = 7) 
SV (ml/beat) (n = 6) 
RA 
3.8 i o..s 
432 10 
-. 
24% 
.- 
3.5 ! 0.5 
42 r 10 
&YF” 
40% 
3.2 + f!.4 
38 I9 
1004”r 
2.9 i- OS 
35 t ut 
Main Statistical Effects 
(one-way analysis of 
variance) 
F = 17.U 
p < 0.0@01 
F = 4.6 
p < 0.017 
PCWP (mm Hg) (n = 7) 28 r 5 30 2 5 32 + 5 32 2 5 i = 2. 
P = NS (~0.08) 
i% (n = 7) (mm Hg) 42 t 7 4026 ?I +6 41 -t6 F = 0.65 
p = NS 
PVR @yiK&m5) (n = 7) 294i-4s ?79 ? 58 238 f 42 321 + 7s F = 0.8 
p = NS 
SVR (dyne~cm’) (n = 7) 1,753 t- 199 2.010 z 229 2.057 t 234 2.346 I 300: F = 6.1 
p < 0.005 
HR (kar~min) (n = 6) 102 f 12 IW~lJ 98 c 1-I 99% 14 F = 0.3 
p = NS 
MAP (mm Hg) (n = 7) 01 25 97 ? 5 92 -t 3 92 T 2 F = 0.8 
p = NS 
MV 0, (;T (mlidl) (n = 6) 9.7 f I .3 Y.5 f 1.2 10.4 i- 1.3 11.0 + 1.3t F = 5.9 
p = 0.007 
sao, (%)’ (n = 7) 93.6 2 1.5 Y6.1 2 1.2 98. I t 0.09 100.0 r 0.0 F = 15.5 
p < 0.0001 
‘All values d&rest from one another (p < 0.01 for all comparisons) using Newman-K& post hoc analysis. *Different from room hir (RA) and 24% oxygen. 
@i&rent from room air (p 5 0.01). CO = cardiac output; SV = stroke volume: PCWP = pulmonary capillary wedge pressure; z = mean pu monmy artery pressure; 
PVR = pulmosary vascular resistance; SVR = systemic vascular resistance; HR = heart rate; MAP = mean arterial blood pressure; MV O- 0 = mixed venous oxygen 
conterit; SsO1 = arterial oxygen saturation 
ventilation (6.8 + 0.2 vs. 7.0 ? 0.2 literstmin, p = NS) and 
end-tidal carbon dioxide (5.4 t 0.1% vs. 5.7 t O.l%, p = NS) 
were unchanged by supplemental oxygen. 
Discussion 
Study findings. In the present report we have demon- 
strated that supplemental oxygen had a potentially deleterious 
effect on hemodynamic variables in class III and IV congestive 
heart failure. Experiment 1 demonstrated that the administra- 
tion of 100% oxygen to these patients resulted in reduced 
Figure 2. Hemodynamic responses to three levels of supplemental 
oxygen in experiment 2 for individual subjects. Vertical bars nitb large 
squares = mean value i: SE. Statistics are presented in Table 3. Open 
qnaws and diamrmds = the two subjects in whom the sequence of 
supplemental oxygen delivery was reversed. 
6 
6 
cardiac output and stroke volume, increased pulmonary capil- 
lary wedge pressure and increased systemic vascular resistance. 
The 100% oxygen did not change blood pressure or heart rate. 
In experiment 2, the results suggested that graded concentra- 
tions of supplemental oxygen caused a progressive decline in 
cardiac output. In experiment 3, we observed no change in 
muscle sympathetic nerve activity or in ventilatory variables 
with oxygen administration. We believe that our findings are of 
potential clinical significance because oxygen is commonly 
used during the hospital period in symptomatic patients with 
heart failure, and subjects with class III and IV heart faiure 
often have precariously Iow cardiac outputs and elevated left 
ventricular filling pressure values at rest. 
Previous work. Previous studies have investigated the he- 
modynamic responses to high concentrations of oxygen admin- 
istered to normal subjects (3,13), patients with acute myocar- 
dial infarction (4) and those with primary pulmonary diseases. 
These studies have demonstrated a characteristic pattern of 
hemodynamic effects, including decreases in cardiac output 
and heart rate and increased systemic vascular resistance and 
blood pressure. Of note, oxygen administration may decrease 
coronary blood flow, cardiac contractility and systemic oxygen 
consumption (13-15). 
Our results in patients with congestive heart failure resem- 
ble those seen in normal human subjects in earlier studies 
(2.3). There are some important differences, however. The 
significant increase in pulmonary capillary wedge pressure 
after 100% oxygen in this group was not seen in earlier studies 
(15). Additionally, heart rate did not change in our heart 
JACC Vol. 27, No. 2 
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failure patients as compared to reductions seen in previously 
studied normal subjects (2-4). Because heart rate did not fall 
as oxygen was administered, the fall in cardiac output that we 
observed must have resulted entirely from a decrease m stroke 
volume. 
Potential mechanisms. The underlying mechanisms re- 
sponsible for our results are unclear. Activation of various 
neurohumoral mechanisms may have been responsible for 
some of the described hemodynamic responses. However, we 
observed no change in muscle sympathetic nerve activity, and 
this suggests a nonneural, direct effect of oxygen. 
Pilot data from one subject with end-stage heart failure who 
required a left ventricular assist device provide evidence that 
the presumed nonneural effect observed in our report may 
have been related to the effects of oxygen on the peripheral 
circulation and not to a primary cardiac effect. In this one 
subject, we held the assist device cardiac output constant. 
Using echocardiography, we determined that native cardiac 
output was negligible (the aortic value did not open). At rest 
this subject was receiving 2 literslmin oxygen via nasal cannula. 
We then gave this subject 100% oxygen to breathe for 5 min. 
This caused mean blocd pressure to rise from 80 to 90 mm Hg. 
After 100% oxygen was removed and nasal cannula was 
replaced, blood pressure fell to 84 mm Hg. Because oiltput was 
held constant, the rise in blood pressure must have resulted 
from an increase in peripheral vascular resistance. Further 
experiments in these interesting subjects will be required to 
characterize this presumed nonneural, noncardiac effect of 
oxygen. 
It should be emphasized that prior data do indeed suggest 
;hat oxygen has effects on the peripheral circulation, act@ 
eithe, directly or through vasoactive autacoids such as 
endothelium-derived relaxing factor (16-18) or prostaglandins 
(19). Endothelium-derived relaxing factor, believed to be nitric 
oxide or a related compound, may mediate the peripheral 
vasodilation seen in hypoxia because hypoxia leads to the 
release of endothelium-derived reiaxing factor (17,18). Hyper- 
oxia, in contrast, attenuates the endotheliumdependent relax- 
ation of vascular smooth muscle. Superoxide anions and 
hyperoxia have been shown to inactivate endotheliumderived 
relaxing factor, one of the most important vasodilators in- 
volved in circulatory control (16,20). Interestingly, the hemo- 
dynamic effects of inhibitors of nitric oxide resemble those 
seen with 100% oxygen in our siudy (21). 
Altenintive s aud conchis~. Because mean 
arterial pressure was unchanged and stroke volume fell, de- 
rived stroke work also fell. This could be considered a benefi- 
cial effect of hyperoxia on myocardial dynamics. However. it 
must be emphasized that this fall in stroke work was associated 
with an increase in left ventricular filling pressures. The 
$ential negative impact of thii increase in pulmonary capil- 
iarywedgepressureonmyocz&aloxygenamsm@onand 
coronarybbodflowandthesensationofdyspneacanoniybe 
surmised. Addition& veutilatory and hem- experi- 
ments will be necezxuy to clarify this important issue. 
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Conclusions. The present study demonstrates that in pa- 
tients with severe congestive heart failure, a significant and 
possibly detrimental effect on hemodynamic variables may be 
seen after shbrt-term administration of oxygen, and this effect 
is independent of the sympathetic nervous system. On the basis 
of our findings, we would suggest that in the absence of 
substantial arterial desaturation, supplemental oxygen should 
be used cautiously during the hospital period in subjects with 
severe heart failure. 
We are indebted to Jennie Sroner and Kathy Vradenburgb for expert typing of 
the manuscript and Kristen Gray for technical assistance and data anah&. 
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